<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05623449</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2022/34</org_study_id>
    <nct_id>NCT05623449</nct_id>
  </id_info>
  <brief_title>Teleconsultations Hypnosis Sessions for Patients With Peripheral Chronic Neuropathic Pain</brief_title>
  <acronym>HYPTEC</acronym>
  <official_title>Monocentric Pilot Study of the Feasibility of Teleconsultations Hypnosis Sessions Led by a Nurse for Patients With Peripheral Chronic Neuropathic Pain - HYPTEC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the feasibility of hypnosis sessions performed in&#xD;
      teleconsultations and led by a nurse, for patients with peripheral chronic neuropathic pain.&#xD;
      Acceptability, satisfaction and effects (on pain and psychological distress) are also&#xD;
      evaluated, comparing patients who have benefited from teleconsultations and those who did&#xD;
      not.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Factors explaining peripheral chronic neuropathic pains are complex ; they require a&#xD;
      personalized therapeutic strategy and multidisciplinary management. Among the recommended&#xD;
      management, psychocorporal approaches such as hypnosis, are subject of recent interest. At&#xD;
      the CHU de Bordeaux, the management of patients suffering from such chronic pains, consists&#xD;
      of 5 hypnosis sessions, conducted face-to-face, each performed one month apart : the first&#xD;
      session is carried out by a doctor and a hypnotherapist nurse and the 4 following sessions by&#xD;
      the hypnotherapist nurse alone. However, it seems that this usual management is not easily&#xD;
      accessible for patients who are geographically distant and/or who are unable to move due to&#xD;
      excessive pain. In such situations, teleconsultations would avoid travel for these patients&#xD;
      with low mobility and then would an interesting alternative to face-to-face consultations.&#xD;
      Few studies have been done on hypnosis sessions led by teleconsultations. So, the whole&#xD;
      purpose of this study is to compare the management of 15 patients by teleconsultations&#xD;
      (experimental arm) with 15 other patients seen in face-to-face (control arm) to evaluate&#xD;
      feasibility of teleconsultation in hypnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2022</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>5 hypnosis consultations (in face-to-face and by teleconsultation).</measure>
    <time_frame>Month 8</time_frame>
    <description>The rate (%) of included patients who have completed the 5 hypnosis consultations (in face-to-face and by teleconsultation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Achievement/Acceptability</measure>
    <time_frame>Month 8</time_frame>
    <description>Acceptance rate (%) of the proposal to participate in the study in the two study arms: face-to-face hypnosis care (control arm) and care including hypnosis teleconsultations (experimental arm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Pain Assessme</measure>
    <time_frame>Day 0, month 1, month 2, month 3 month 4 and montth 7</time_frame>
    <description>Mean difference in pain score, minimum value is 0 and maximum value is 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression scale (HAD)</measure>
    <time_frame>Day 0, month 4 and month 7</time_frame>
    <description>Mean difference in the anxiety and depression score, minimum value is 0 and maximum value is 42</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning self-hypnosis</measure>
    <time_frame>Day 0, month 1, month 2, month 3 month 4 and montth 7</time_frame>
    <description>Evaluate the frequency of the use of self-hypnosis throughout the treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ssatisfaction scale</measure>
    <time_frame>Month 7</time_frame>
    <description>Evaluate the level of satisfaction and the feeling of the patients with regard to the nursing care in hypnosis at the end of the care in the two study arms (face-to-face control arm and experimental arm with teleconsultations).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peripheral Neuropathy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The first and the last hypnosis sessions in face-to-face, and the other 3 intermediate sessions being conducted by teleconsultation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 face-to-face hypnosis sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical examination</intervention_name>
    <description>Current medications (only those prescribed to treat pain, anxiety and depression), non-drug treatment(s) prior to treatment in hypnosis as well as any ongoing treatment(s).</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety and Depression Scale (HAD)</intervention_name>
    <description>To screen for anxious and depressive symptoms</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pain scale</intervention_name>
    <description>Measurement of pain intensity</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hypnosis consultation</intervention_name>
    <description>5 hypnosis consultation</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maintenance</intervention_name>
    <description>Qualitative assessment</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Age, sex, socio-professional category, level of education, comorbidities, date of diagnosis of chronic peripheral neuropathic pain, distance between home and hospital.</description>
    <arm_group_label>combination of face-to-face and teleconsultation hypnosis consultation</arm_group_label>
    <arm_group_label>face-to-face hypnosis consultation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged over 18 years old,&#xD;
&#xD;
          -  Patient suffering of from peripheral neuropathic pain for more than 1 year,&#xD;
&#xD;
          -  Patient referred for hypnosis management as part of a coordinated care support,&#xD;
&#xD;
          -  Patient who accepts teleconsultation, having the appropriate equipment to attend&#xD;
             teleconsultations (computer, microphone, camera and stable internet connection with&#xD;
             sufficient internet speed) and the ability to use it independently,&#xD;
&#xD;
          -  Patient having signed a free, informed and written consent,&#xD;
&#xD;
          -  Patient affiliated or beneficiary of the social security system.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with severe and unstable neurocognitive or psychiatric conditions (depression,&#xD;
             psychoses, major cognitive impairments),&#xD;
&#xD;
          -  Patient with uncorrected deafness,&#xD;
&#xD;
          -  Patient with poor understanding of French&#xD;
&#xD;
          -  Patient placed under judicial safeguard, guardianship or curatorship.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennie SOURZAC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√© Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennie SOURZAC</last_name>
    <phone>0677551606</phone>
    <email>jennie.sourzac@chu-bordeaux.fr</email>
  </overall_contact>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 27, 2022</study_first_submitted>
  <study_first_submitted_qc>November 17, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2022</study_first_posted>
  <last_update_submitted>November 17, 2022</last_update_submitted>
  <last_update_submitted_qc>November 17, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peripheral chronic neuropathic pain</keyword>
  <keyword>hypnosis</keyword>
  <keyword>teleconsultations</keyword>
  <keyword>feasability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

